[NEJM] Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis

Sweetums33 Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-08-27 08:56
Reward100points

journalㄩNew England Journal of Medicine

Authorsㄩivind Torkildsen; Hilde Kjelgaard Brustad; Einar August Hgestl; Karl Bjrnar Alstadhaug; Alok Bhan; Heidi yen Flemmen; Andrea Habbestad; Rune A.A. Hglund; Marissa LeBlanc; Peter Lopen; slaug Rudjord Lorentzen; se Hagen Morsund; Andreas Lossius; Rigmor Lundby; Gro O. Nygaard; Brit Ellen Rd; Cecilia Smith Simonsen; Linn Steffensen; Hilde Torgauten; Fredrik Piehl; Stig Wergeland; Kjell-Morten Myhr

Published dateㄩ2026-7-2

DOIㄩ10.1056/nejmoa2600993

PDF linkㄩhttp://www.nejm.org/doi/pdf/10.1056/NEJMoa2600993

Article linkㄩhttps://doi.org/10.1056/nejmoa2600993

Article SourceㄩMassachusetts Medical Society


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Georgee Post time Half hour(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    246882

Same Category


Return to the list